Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 900 shares at $133.17 ($120K) on 2018-12-10, disclosed to the SEC on 2018-12-12.
Open-market sale of $120k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LOXO | SELL | 2018-12-12 | $426K | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |
| LOXO | SELL | 2018-11-28 | $487K | — | Filing → |